nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Fluorouracil—head and neck cancer	0.451	1	CbGbCtD
Gatifloxacin—Chronic conjunctivitis—Fluorouracil—head and neck cancer	0.137	0.249	CcSEcCtD
Gatifloxacin—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00799	0.0145	CcSEcCtD
Gatifloxacin—Bone pain—Vinblastine—head and neck cancer	0.00753	0.0137	CcSEcCtD
Gatifloxacin—Photophobia—Vinblastine—head and neck cancer	0.00677	0.0123	CcSEcCtD
Gatifloxacin—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00598	0.0109	CcSEcCtD
Gatifloxacin—Eye irritation—Fluorouracil—head and neck cancer	0.00555	0.0101	CcSEcCtD
Gatifloxacin—Oral candidiasis—Docetaxel—head and neck cancer	0.00538	0.00979	CcSEcCtD
Gatifloxacin—Parosmia—Docetaxel—head and neck cancer	0.00527	0.00959	CcSEcCtD
Gatifloxacin—Renal failure acute—Hydroxyurea—head and neck cancer	0.00517	0.00941	CcSEcCtD
Gatifloxacin—Lacrimation increased—Fluorouracil—head and neck cancer	0.00514	0.00935	CcSEcCtD
Gatifloxacin—Redness—Docetaxel—head and neck cancer	0.00506	0.00921	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.005	0.00909	CcSEcCtD
Gatifloxacin—Throat sore—Docetaxel—head and neck cancer	0.00474	0.00863	CcSEcCtD
Gatifloxacin—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.0047	0.00855	CcSEcCtD
Gatifloxacin—Face oedema—Hydroxyurea—head and neck cancer	0.00461	0.00839	CcSEcCtD
Gatifloxacin—Photophobia—Fluorouracil—head and neck cancer	0.00445	0.00809	CcSEcCtD
Gatifloxacin—Rash maculo-papular—Fluorouracil—head and neck cancer	0.0043	0.00783	CcSEcCtD
Gatifloxacin—Rhinorrhoea—Docetaxel—head and neck cancer	0.00422	0.00768	CcSEcCtD
Gatifloxacin—Ageusia—Docetaxel—head and neck cancer	0.00422	0.00768	CcSEcCtD
Gatifloxacin—Euphoric mood—Fluorouracil—head and neck cancer	0.00407	0.0074	CcSEcCtD
Gatifloxacin—Pancreatitis—Hydroxyurea—head and neck cancer	0.00405	0.00736	CcSEcCtD
Gatifloxacin—Eye irritation—Docetaxel—head and neck cancer	0.004	0.00728	CcSEcCtD
Gatifloxacin—Photosensitivity—Fluorouracil—head and neck cancer	0.00391	0.00712	CcSEcCtD
Gatifloxacin—Dysuria—Hydroxyurea—head and neck cancer	0.00386	0.00702	CcSEcCtD
Gatifloxacin—Neutropenia—Hydroxyurea—head and neck cancer	0.00386	0.00702	CcSEcCtD
Gatifloxacin—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00376	0.00684	CcSEcCtD
Gatifloxacin—Lacrimation increased—Docetaxel—head and neck cancer	0.00371	0.00675	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Fluorouracil—head and neck cancer	0.0036	0.00654	CcSEcCtD
Gatifloxacin—Pharyngitis—Vinblastine—head and neck cancer	0.0036	0.00654	CcSEcCtD
Gatifloxacin—Stomatitis—Hydroxyurea—head and neck cancer	0.00359	0.00653	CcSEcCtD
Gatifloxacin—Bone pain—Docetaxel—head and neck cancer	0.00357	0.00649	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00344	0.00625	CcSEcCtD
Gatifloxacin—Injection site reaction—Docetaxel—head and neck cancer	0.0034	0.00618	CcSEcCtD
Gatifloxacin—Hallucination—Hydroxyurea—head and neck cancer	0.00329	0.00598	CcSEcCtD
Gatifloxacin—Colitis—Docetaxel—head and neck cancer	0.00328	0.00597	CcSEcCtD
Gatifloxacin—Candida infection—Docetaxel—head and neck cancer	0.00326	0.00594	CcSEcCtD
Gatifloxacin—Fluid retention—Docetaxel—head and neck cancer	0.00324	0.0059	CcSEcCtD
Gatifloxacin—Ataxia—Fluorouracil—head and neck cancer	0.00323	0.00588	CcSEcCtD
Gatifloxacin—Dry skin—Fluorouracil—head and neck cancer	0.00315	0.00573	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00307	0.00559	CcSEcCtD
Gatifloxacin—Muscular weakness—Fluorouracil—head and neck cancer	0.00303	0.00552	CcSEcCtD
Gatifloxacin—Dysphagia—Fluorouracil—head and neck cancer	0.00297	0.00541	CcSEcCtD
Gatifloxacin—Chills—Hydroxyurea—head and neck cancer	0.00296	0.00539	CcSEcCtD
Gatifloxacin—Erythema—Hydroxyurea—head and neck cancer	0.00288	0.00523	CcSEcCtD
Gatifloxacin—Vertigo—Vinblastine—head and neck cancer	0.00283	0.00516	CcSEcCtD
Gatifloxacin—Convulsion—Vinblastine—head and neck cancer	0.00273	0.00497	CcSEcCtD
Gatifloxacin—Hypertension—Vinblastine—head and neck cancer	0.00272	0.00495	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00271	0.00493	CcSEcCtD
Gatifloxacin—Renal impairment—Docetaxel—head and neck cancer	0.00261	0.00474	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Docetaxel—head and neck cancer	0.0026	0.00472	CcSEcCtD
Gatifloxacin—Stomatitis—Fluorouracil—head and neck cancer	0.00258	0.0047	CcSEcCtD
Gatifloxacin—Conjunctivitis—Fluorouracil—head and neck cancer	0.00257	0.00469	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00252	0.00459	CcSEcCtD
Gatifloxacin—Epistaxis—Fluorouracil—head and neck cancer	0.0025	0.00455	CcSEcCtD
Gatifloxacin—Convulsion—Hydroxyurea—head and neck cancer	0.00249	0.00453	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00248	0.00451	CcSEcCtD
Gatifloxacin—Anorexia—Vinblastine—head and neck cancer	0.00245	0.00446	CcSEcCtD
Gatifloxacin—Migraine—Docetaxel—head and neck cancer	0.00244	0.00444	CcSEcCtD
Gatifloxacin—Pharyngitis—Fluorouracil—head and neck cancer	0.00236	0.00429	CcSEcCtD
Gatifloxacin—Oedema—Hydroxyurea—head and neck cancer	0.00235	0.00427	CcSEcCtD
Gatifloxacin—Ataxia—Docetaxel—head and neck cancer	0.00233	0.00425	CcSEcCtD
Gatifloxacin—Infection—Hydroxyurea—head and neck cancer	0.00233	0.00424	CcSEcCtD
Gatifloxacin—Paraesthesia—Vinblastine—head and neck cancer	0.00231	0.00421	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0023	0.00418	CcSEcCtD
Gatifloxacin—Dry skin—Docetaxel—head and neck cancer	0.00227	0.00414	CcSEcCtD
Gatifloxacin—Anorexia—Hydroxyurea—head and neck cancer	0.00224	0.00407	CcSEcCtD
Gatifloxacin—Decreased appetite—Vinblastine—head and neck cancer	0.00224	0.00407	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Docetaxel—head and neck cancer	0.00222	0.00404	CcSEcCtD
Gatifloxacin—Constipation—Vinblastine—head and neck cancer	0.0022	0.004	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00219	0.00398	CcSEcCtD
Gatifloxacin—Dysphagia—Docetaxel—head and neck cancer	0.00214	0.0039	CcSEcCtD
Gatifloxacin—Feeling abnormal—Vinblastine—head and neck cancer	0.00212	0.00386	CcSEcCtD
Gatifloxacin—Bronchospasm—Docetaxel—head and neck cancer	0.00211	0.00384	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0021	0.00383	CcSEcCtD
Gatifloxacin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00209	0.00381	CcSEcCtD
Gatifloxacin—Somnolence—Hydroxyurea—head and neck cancer	0.00209	0.0038	CcSEcCtD
Gatifloxacin—Erythema—Fluorouracil—head and neck cancer	0.00207	0.00377	CcSEcCtD
Gatifloxacin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00207	0.00376	CcSEcCtD
Gatifloxacin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00204	0.00371	CcSEcCtD
Gatifloxacin—Abdominal pain—Vinblastine—head and neck cancer	0.00203	0.0037	CcSEcCtD
Gatifloxacin—Constipation—Hydroxyurea—head and neck cancer	0.00201	0.00365	CcSEcCtD
Gatifloxacin—Neutropenia—Docetaxel—head and neck cancer	0.00201	0.00365	CcSEcCtD
Gatifloxacin—Vision blurred—Fluorouracil—head and neck cancer	0.00195	0.00355	CcSEcCtD
Gatifloxacin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00193	0.00352	CcSEcCtD
Gatifloxacin—Hypersensitivity—Vinblastine—head and neck cancer	0.0019	0.00345	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.0019	0.00345	CcSEcCtD
Gatifloxacin—Stomatitis—Docetaxel—head and neck cancer	0.00186	0.00339	CcSEcCtD
Gatifloxacin—Conjunctivitis—Docetaxel—head and neck cancer	0.00186	0.00338	CcSEcCtD
Gatifloxacin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00186	0.00338	CcSEcCtD
Gatifloxacin—Asthenia—Vinblastine—head and neck cancer	0.00185	0.00336	CcSEcCtD
Gatifloxacin—Epistaxis—Docetaxel—head and neck cancer	0.0018	0.00328	CcSEcCtD
Gatifloxacin—Convulsion—Fluorouracil—head and neck cancer	0.00179	0.00326	CcSEcCtD
Gatifloxacin—Chest pain—Fluorouracil—head and neck cancer	0.00176	0.00321	CcSEcCtD
Gatifloxacin—Myalgia—Fluorouracil—head and neck cancer	0.00176	0.00321	CcSEcCtD
Gatifloxacin—Diarrhoea—Vinblastine—head and neck cancer	0.00176	0.0032	CcSEcCtD
Gatifloxacin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00173	0.00315	CcSEcCtD
Gatifloxacin—Hepatitis—Docetaxel—head and neck cancer	0.00172	0.00312	CcSEcCtD
Gatifloxacin—Confusional state—Fluorouracil—head and neck cancer	0.0017	0.0031	CcSEcCtD
Gatifloxacin—Pharyngitis—Docetaxel—head and neck cancer	0.0017	0.0031	CcSEcCtD
Gatifloxacin—Dizziness—Vinblastine—head and neck cancer	0.0017	0.0031	CcSEcCtD
Gatifloxacin—Oedema peripheral—Docetaxel—head and neck cancer	0.00169	0.00308	CcSEcCtD
Gatifloxacin—Oedema—Fluorouracil—head and neck cancer	0.00169	0.00307	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00169	0.00307	CcSEcCtD
Gatifloxacin—Asthenia—Hydroxyurea—head and neck cancer	0.00168	0.00306	CcSEcCtD
Gatifloxacin—Infection—Fluorouracil—head and neck cancer	0.00168	0.00305	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00165	0.00301	CcSEcCtD
Gatifloxacin—Visual impairment—Docetaxel—head and neck cancer	0.00165	0.00301	CcSEcCtD
Gatifloxacin—Tachycardia—Fluorouracil—head and neck cancer	0.00165	0.003	CcSEcCtD
Gatifloxacin—Vomiting—Vinblastine—head and neck cancer	0.00164	0.00298	CcSEcCtD
Gatifloxacin—Erythema multiforme—Docetaxel—head and neck cancer	0.00162	0.00295	CcSEcCtD
Gatifloxacin—Headache—Vinblastine—head and neck cancer	0.00161	0.00293	CcSEcCtD
Gatifloxacin—Anorexia—Fluorouracil—head and neck cancer	0.00161	0.00293	CcSEcCtD
Gatifloxacin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00161	0.00292	CcSEcCtD
Gatifloxacin—Eye disorder—Docetaxel—head and neck cancer	0.0016	0.00292	CcSEcCtD
Gatifloxacin—Hypotension—Fluorouracil—head and neck cancer	0.00158	0.00287	CcSEcCtD
Gatifloxacin—Dizziness—Hydroxyurea—head and neck cancer	0.00155	0.00282	CcSEcCtD
Gatifloxacin—Chills—Docetaxel—head and neck cancer	0.00154	0.0028	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00154	0.0028	CcSEcCtD
Gatifloxacin—Nausea—Vinblastine—head and neck cancer	0.00153	0.00278	CcSEcCtD
Gatifloxacin—Insomnia—Fluorouracil—head and neck cancer	0.00153	0.00278	CcSEcCtD
Gatifloxacin—Paraesthesia—Fluorouracil—head and neck cancer	0.00152	0.00276	CcSEcCtD
Gatifloxacin—Dyspnoea—Fluorouracil—head and neck cancer	0.00151	0.00274	CcSEcCtD
Gatifloxacin—Somnolence—Fluorouracil—head and neck cancer	0.0015	0.00273	CcSEcCtD
Gatifloxacin—Erythema—Docetaxel—head and neck cancer	0.00149	0.00272	CcSEcCtD
Gatifloxacin—Vomiting—Hydroxyurea—head and neck cancer	0.00149	0.00272	CcSEcCtD
Gatifloxacin—Dyspepsia—Fluorouracil—head and neck cancer	0.00149	0.00271	CcSEcCtD
Gatifloxacin—Rash—Hydroxyurea—head and neck cancer	0.00148	0.00269	CcSEcCtD
Gatifloxacin—Dermatitis—Hydroxyurea—head and neck cancer	0.00148	0.00269	CcSEcCtD
Gatifloxacin—Headache—Hydroxyurea—head and neck cancer	0.00147	0.00268	CcSEcCtD
Gatifloxacin—Decreased appetite—Fluorouracil—head and neck cancer	0.00147	0.00267	CcSEcCtD
Gatifloxacin—Dysgeusia—Docetaxel—head and neck cancer	0.00146	0.00266	CcSEcCtD
Gatifloxacin—Back pain—Docetaxel—head and neck cancer	0.00145	0.00263	CcSEcCtD
Gatifloxacin—Muscle spasms—Docetaxel—head and neck cancer	0.00144	0.00261	CcSEcCtD
Gatifloxacin—Nausea—Hydroxyurea—head and neck cancer	0.00139	0.00254	CcSEcCtD
Gatifloxacin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00139	0.00253	CcSEcCtD
Gatifloxacin—Urticaria—Fluorouracil—head and neck cancer	0.00134	0.00244	CcSEcCtD
Gatifloxacin—Syncope—Docetaxel—head and neck cancer	0.00134	0.00244	CcSEcCtD
Gatifloxacin—Body temperature increased—Fluorouracil—head and neck cancer	0.00134	0.00243	CcSEcCtD
Gatifloxacin—Palpitations—Docetaxel—head and neck cancer	0.00132	0.0024	CcSEcCtD
Gatifloxacin—Loss of consciousness—Docetaxel—head and neck cancer	0.00131	0.00239	CcSEcCtD
Gatifloxacin—Convulsion—Docetaxel—head and neck cancer	0.00129	0.00236	CcSEcCtD
Gatifloxacin—Hypertension—Docetaxel—head and neck cancer	0.00129	0.00235	CcSEcCtD
Gatifloxacin—Chest pain—Docetaxel—head and neck cancer	0.00127	0.00231	CcSEcCtD
Gatifloxacin—Myalgia—Docetaxel—head and neck cancer	0.00127	0.00231	CcSEcCtD
Gatifloxacin—Arthralgia—Docetaxel—head and neck cancer	0.00127	0.00231	CcSEcCtD
Gatifloxacin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00124	0.00226	CcSEcCtD
Gatifloxacin—Confusional state—Docetaxel—head and neck cancer	0.00123	0.00224	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Docetaxel—head and neck cancer	0.00122	0.00222	CcSEcCtD
Gatifloxacin—Oedema—Docetaxel—head and neck cancer	0.00122	0.00222	CcSEcCtD
Gatifloxacin—Infection—Docetaxel—head and neck cancer	0.00121	0.0022	CcSEcCtD
Gatifloxacin—Shock—Docetaxel—head and neck cancer	0.0012	0.00218	CcSEcCtD
Gatifloxacin—Pruritus—Fluorouracil—head and neck cancer	0.0012	0.00218	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Docetaxel—head and neck cancer	0.00119	0.00217	CcSEcCtD
Gatifloxacin—Tachycardia—Docetaxel—head and neck cancer	0.00119	0.00217	CcSEcCtD
Gatifloxacin—Anorexia—Docetaxel—head and neck cancer	0.00116	0.00212	CcSEcCtD
Gatifloxacin—Diarrhoea—Fluorouracil—head and neck cancer	0.00116	0.0021	CcSEcCtD
Gatifloxacin—Hypotension—Docetaxel—head and neck cancer	0.00114	0.00207	CcSEcCtD
Gatifloxacin—Dizziness—Fluorouracil—head and neck cancer	0.00112	0.00203	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00111	0.00202	CcSEcCtD
Gatifloxacin—Insomnia—Docetaxel—head and neck cancer	0.0011	0.00201	CcSEcCtD
Gatifloxacin—Paraesthesia—Docetaxel—head and neck cancer	0.00109	0.00199	CcSEcCtD
Gatifloxacin—Dyspnoea—Docetaxel—head and neck cancer	0.00109	0.00198	CcSEcCtD
Gatifloxacin—Somnolence—Docetaxel—head and neck cancer	0.00108	0.00197	CcSEcCtD
Gatifloxacin—Vomiting—Fluorouracil—head and neck cancer	0.00107	0.00195	CcSEcCtD
Gatifloxacin—Dyspepsia—Docetaxel—head and neck cancer	0.00107	0.00195	CcSEcCtD
Gatifloxacin—Rash—Fluorouracil—head and neck cancer	0.00107	0.00194	CcSEcCtD
Gatifloxacin—Dermatitis—Fluorouracil—head and neck cancer	0.00106	0.00194	CcSEcCtD
Gatifloxacin—Decreased appetite—Docetaxel—head and neck cancer	0.00106	0.00193	CcSEcCtD
Gatifloxacin—Headache—Fluorouracil—head and neck cancer	0.00106	0.00193	CcSEcCtD
Gatifloxacin—Constipation—Docetaxel—head and neck cancer	0.00104	0.0019	CcSEcCtD
Gatifloxacin—Feeling abnormal—Docetaxel—head and neck cancer	0.001	0.00183	CcSEcCtD
Gatifloxacin—Nausea—Fluorouracil—head and neck cancer	0.001	0.00183	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000997	0.00181	CcSEcCtD
Gatifloxacin—Abdominal pain—Docetaxel—head and neck cancer	0.000964	0.00175	CcSEcCtD
Gatifloxacin—Body temperature increased—Docetaxel—head and neck cancer	0.000964	0.00175	CcSEcCtD
Gatifloxacin—Hypersensitivity—Docetaxel—head and neck cancer	0.000898	0.00163	CcSEcCtD
Gatifloxacin—Asthenia—Docetaxel—head and neck cancer	0.000875	0.00159	CcSEcCtD
Gatifloxacin—Pruritus—Docetaxel—head and neck cancer	0.000863	0.00157	CcSEcCtD
Gatifloxacin—Diarrhoea—Docetaxel—head and neck cancer	0.000834	0.00152	CcSEcCtD
Gatifloxacin—Dizziness—Docetaxel—head and neck cancer	0.000806	0.00147	CcSEcCtD
Gatifloxacin—Vomiting—Docetaxel—head and neck cancer	0.000775	0.00141	CcSEcCtD
Gatifloxacin—Rash—Docetaxel—head and neck cancer	0.000769	0.0014	CcSEcCtD
Gatifloxacin—Dermatitis—Docetaxel—head and neck cancer	0.000768	0.0014	CcSEcCtD
Gatifloxacin—Headache—Docetaxel—head and neck cancer	0.000764	0.00139	CcSEcCtD
Gatifloxacin—Nausea—Docetaxel—head and neck cancer	0.000724	0.00132	CcSEcCtD
